Commission Decision of 13 April 2007 on the implementation of surveillance programmes for avian influenza in poultry and wild birds to be carried out in the Member States and amending Decision 2004/450/EC (notified under document number C(2007) 1554) (2007/268/EC) (repealed)
EU Decision 2007/268 · Adopted 3 May 2007 · Extends to United Kingdom
Commission Decision
of 13 April 2007
on the implementation of surveillance programmes for avian influenza in poultry and wild birds to be carried out in the Member States and amending Decision 2004/450/EC
(notified under document number C(2007) 1554)
(2007/268/EC) (repealed)
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annotations to the whole text
Textual amendments
Contents
- 1Approval of surveillance programmes for avian influenza Repealed
- 2Amendments to Decision 2004/450/EC Repealed
- 3Article 3 Repealed
- Annex I: Guidelines on the implementation of surveillance programmes for avian influenza in poultry to be carried out in the Member States Repealed
- Objectives, general requirements and criteria for surveillance Repealed
- A.1Objectives Repealed
- General requirements and criteria Repealed
- 1Division 1 Repealed
- 2Division 2 Repealed
- 3Division 3 Repealed
- 4Division 4 Repealed
- 5Division 5 Repealed
- 6Division 6 Repealed
- BSurveillance for avian influenza in poultry Repealed
- 1Division 1 Repealed
- 2Division 2 Repealed
- 3Division 3 Repealed
- 4Sampling shall be stratified throughout the territory of the whole Member State, so that samples can be considered as representative for the whole of the Member State, taking into account: Repealed
- 5Based on a risk assessment and the specific situation in the Member State concerned, the sampling design shall also consider: Repealed
- Specific requirements for detection of infections with H5/H7 subtypes of avian influenza in ducks, geese and quail Repealed
- 1Division 1 Repealed
- 2Division 2 Repealed
- 3Division 3 Repealed
- Laboratory testing Repealed
- 1Division 1 Repealed
- 2Division 2 Repealed
- 3All positive serological findings shall be confirmed by the NL by a haemagglutination-inhibition test, using designated strains supplied by the CRL: Repealed
- Annex II: Guidelines on the implementation of surveillance programmes for avian influenza in wild birds to be carried out in the Member States Repealed
- Objectives, general requirements and criteria for surveillance Repealed
- A1Objectives Repealed
- General requirements and criteria Repealed
- 1Division 1 Repealed
- 2Division 2 Repealed
- 3Division 3 Repealed
- 4Division 4 Repealed
- Surveillance for avian influenza in wild birds Repealed
- Design and implementation Repealed
- Sampling procedures Repealed
- 1Division 1 Repealed
- 2Division 2 Repealed
- 3Division 3 Repealed
- 4Division 4 Repealed
- Laboratory testing Repealed
- 1Division 1 Repealed
- 2Division 2 Repealed
- 3Division 3 Repealed
- 4Division 4 Repealed
- 5Division 5 Repealed
- DDivision D Repealed
- EDivision E Repealed
- Annex IIIAnnex III Repealed
1Approval of surveillance programmes for avian influenzaF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2Amendments to Decision 2004/450/ECF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
A.1ObjectivesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
BSurveillance for avian influenza in poultryF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4Sampling shall be stratified throughout the territory of the whole Member State, so that samples can be considered as representative for the whole of the Member State, taking into account:F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5Based on a risk assessment and the specific situation in the Member State concerned, the sampling design shall also consider:F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3All positive serological findings shall be confirmed by the NL by a haemagglutination-inhibition test, using designated strains supplied by the CRL:F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
A1ObjectivesF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Design and implementation
F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5F1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
DF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
EF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Annex IIIF1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .